Literature DB >> 5289373

The absolute configuration of natural (-)-stercobilin and other urobilinoid compounds.

H Brockmann, G Knobloch, H Plieninger, K Ehl, J Ruppert, A Moscowitz, C J Watson.   

Abstract

Chromic acid degradation of natural (-)-stercobilin (1) yields 2(R)-methyl-3(R)-ethylsuccinimide (+2), whereby the absolute configuration of 1 at the chiral centers C-1, C-2, C-7, and C-8 is established. The substituted oxo-tetrahydrodipyrromethane precursor, 5, for the total synthesis of (-)-stercobilins 3 and 4, in which the relative configuration between the asymmetric centers is known, yields 2(S)-methyl-3(S)-ethylsuccinimide (-2) under the same conditions of degradation. Nuclear magnetic resonance studies of 1 and 3 show that in 1 the hydrogen atoms at C-2 and C-2', as well as those at C-7 and C-7', are trans relative to one another. Accordingly, natural (-)-stercobilin possesses the 2'(S), 7'(S) configuration, and has the configuration formula 6(1 (R), 2(R), 2'(S), 7'(S), 7(R), 8(R)). These results, coupled with those of earlier studies, also establish the absolute configuration of the (+)-urobilin 7 and of the phycobilin 8 at C-7'.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289373      PMCID: PMC389370          DOI: 10.1073/pnas.68.9.2141

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  3 in total

1.  ON THE ORIGIN OF THE OPTICAL ACTIVITY IN THE UROBILINS.

Authors:  A MOSCOWITZ; W C KRUEGER; I T KAY; G SKEWES; S BRUCKENSTEIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

Review 2.  Recent chemistry and biochemistry of bile pigments.

Authors:  W Rüdiger
Journal:  Angew Chem Int Ed Engl       Date:  1970-07       Impact factor: 15.336

3.  The optical activity of urobilins derived from phycoerythrobiln.

Authors:  W J Cole; C O hEocha; A Moscowitz; W R Krueger
Journal:  Eur J Biochem       Date:  1967-12
  3 in total
  1 in total

1.  The structure of mesobilirhodin.

Authors:  D J Chapman; H Budzikiewicz; H W Siegelman
Journal:  Experientia       Date:  1972-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.